Jacek Olczak, Philip Morris International CEO, joins CNBC's 'Money Movers' to discuss the company's most recent earnings.
The number of hospitalizations and deaths from foodborne illness doubled last year compared to 2023 in the U.S.
Reshma Kewalramani, CEO and president of Vertex, called the drug's approval "a historic milestone" in a statement. "We have ...